Cargando…

OCD and COVID-19: a new frontier

People with obsessive compulsive disorder (OCD) are likely to be more susceptible to the mental health impact of COVID-19. This paper shares the perspectives of expert clinicians working with OCD considering how to identify OCD in the context of COVID-19, changes in the presentation, and importantly...

Descripción completa

Detalles Bibliográficos
Autores principales: Jassi, Amita, Shahriyarmolki, Khodayar, Taylor, Tracey, Peile, Lauren, Challacombe, Fiona, Clark, Bruce, Veale, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387744/
https://www.ncbi.nlm.nih.gov/pubmed/34191939
http://dx.doi.org/10.1017/S1754470X20000318
_version_ 1783564188322365440
author Jassi, Amita
Shahriyarmolki, Khodayar
Taylor, Tracey
Peile, Lauren
Challacombe, Fiona
Clark, Bruce
Veale, David
author_facet Jassi, Amita
Shahriyarmolki, Khodayar
Taylor, Tracey
Peile, Lauren
Challacombe, Fiona
Clark, Bruce
Veale, David
author_sort Jassi, Amita
collection PubMed
description People with obsessive compulsive disorder (OCD) are likely to be more susceptible to the mental health impact of COVID-19. This paper shares the perspectives of expert clinicians working with OCD considering how to identify OCD in the context of COVID-19, changes in the presentation, and importantly what to consider when undertaking cognitive behaviour therapy (CBT) for OCD in the current climate. The expert consensus is that although the presentation of OCD and treatment may have become more difficult, CBT should still continue remotely unless there are specific reasons for it not to, e.g. increase in risk, no access to computer, or exposure tasks or behavioural experiments cannot be undertaken. The authors highlight some of the considerations to take in CBT in light of our current understanding of COVID-19, including therapists and clients taking calculated risks when developing behavioural experiments and exposure tasks, considering viral loading and vulnerability factors. Special considerations for young people and perinatal women are discussed, as well as foreseeing what life may be like for those with OCD after the pandemic is over. KEY LEARNING AIMS: (1).. To learn how to identify OCD in the context of COVID-19 and consider the differences between following government guidelines and OCD. (2).. To consider the presentation of OCD in context of COVID-19, with regard to cognitive and behavioural processes. (3).. Review factors to be considered when embarking on CBT for OCD during the pandemic. (4).. Considerations in CBT for OCD, including weighing up costs and benefits of behavioural experiments or exposure tasks in light of our current understanding of the risks associated with COVID-19.
format Online
Article
Text
id pubmed-7387744
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-73877442020-07-29 OCD and COVID-19: a new frontier Jassi, Amita Shahriyarmolki, Khodayar Taylor, Tracey Peile, Lauren Challacombe, Fiona Clark, Bruce Veale, David Cogn Behav Therap Empirically Grounded Clinical Guidance Paper People with obsessive compulsive disorder (OCD) are likely to be more susceptible to the mental health impact of COVID-19. This paper shares the perspectives of expert clinicians working with OCD considering how to identify OCD in the context of COVID-19, changes in the presentation, and importantly what to consider when undertaking cognitive behaviour therapy (CBT) for OCD in the current climate. The expert consensus is that although the presentation of OCD and treatment may have become more difficult, CBT should still continue remotely unless there are specific reasons for it not to, e.g. increase in risk, no access to computer, or exposure tasks or behavioural experiments cannot be undertaken. The authors highlight some of the considerations to take in CBT in light of our current understanding of COVID-19, including therapists and clients taking calculated risks when developing behavioural experiments and exposure tasks, considering viral loading and vulnerability factors. Special considerations for young people and perinatal women are discussed, as well as foreseeing what life may be like for those with OCD after the pandemic is over. KEY LEARNING AIMS: (1).. To learn how to identify OCD in the context of COVID-19 and consider the differences between following government guidelines and OCD. (2).. To consider the presentation of OCD in context of COVID-19, with regard to cognitive and behavioural processes. (3).. Review factors to be considered when embarking on CBT for OCD during the pandemic. (4).. Considerations in CBT for OCD, including weighing up costs and benefits of behavioural experiments or exposure tasks in light of our current understanding of the risks associated with COVID-19. Cambridge University Press 2020-07-14 /pmc/articles/PMC7387744/ /pubmed/34191939 http://dx.doi.org/10.1017/S1754470X20000318 Text en © British Association for Behavioural and Cognitive Psychotherapies 2020 http://creativecommons.org/licenses/by/4.0/ This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Empirically Grounded Clinical Guidance Paper
Jassi, Amita
Shahriyarmolki, Khodayar
Taylor, Tracey
Peile, Lauren
Challacombe, Fiona
Clark, Bruce
Veale, David
OCD and COVID-19: a new frontier
title OCD and COVID-19: a new frontier
title_full OCD and COVID-19: a new frontier
title_fullStr OCD and COVID-19: a new frontier
title_full_unstemmed OCD and COVID-19: a new frontier
title_short OCD and COVID-19: a new frontier
title_sort ocd and covid-19: a new frontier
topic Empirically Grounded Clinical Guidance Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387744/
https://www.ncbi.nlm.nih.gov/pubmed/34191939
http://dx.doi.org/10.1017/S1754470X20000318
work_keys_str_mv AT jassiamita ocdandcovid19anewfrontier
AT shahriyarmolkikhodayar ocdandcovid19anewfrontier
AT taylortracey ocdandcovid19anewfrontier
AT peilelauren ocdandcovid19anewfrontier
AT challacombefiona ocdandcovid19anewfrontier
AT clarkbruce ocdandcovid19anewfrontier
AT vealedavid ocdandcovid19anewfrontier